Invention Grant
US09533954B2 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
有权
取代的咪唑并哒嗪和苯并咪唑作为FGFR3的抑制剂
- Patent Title: Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
- Patent Title (中): 取代的咪唑并哒嗪和苯并咪唑作为FGFR3的抑制剂
-
Application No.: US14267139Application Date: 2014-05-01
-
Publication No.: US09533954B2Publication Date: 2017-01-03
- Inventor: Wenqing Yao , Colin Zhang , Meizhong Xu , Jincong Zhuo , Chunhong He
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D235/06
- IPC: C07D235/06 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D407/12 ; C07D487/04 ; C07D403/04
Abstract:
The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases.
Public/Granted literature
- US20140243308A1 SUBSTITUTED IMIDAZOPYRIDAZINES AND BENZIMIDAZOLES AS INHIBITORS OF FGFR3 Public/Granted day:2014-08-28
Information query
